A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection | MicrobiomeTrials← Back to trialsNCT02765802
A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2016-10-19Est. Completion: 2018-07-20
Enrollment target: 33 participants Locations- Soroka Medical Center, Beersheba, Israel
- Shaare Zedek Medical Center, Jerusalem, Israel
- Auckland City Hospital, Grafton, Auckland, New Zealand
- The Aga Khan University and Hospital, Karachi, Pakistan
Other microbiome trials you might be interested in
Hepatitis DHepatitis CHepatitis BLiver Disease
The proposed study aims to evaluate, investigate, and follow-up patients suffering from acute and chronic liver disease.…
Bethesda, United States
Chronic Hepatitis D
This is a Phase 2b/3, randomized, open-label, multicenter trial evaluating the efficacy and safety of switching from bul…
Graz, AustriaEst. completion Aug 31, 2027